Skip to main content
logo
Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
134.28
0.00 (0.00%)
At close: Jul 27, 2026, 4:00 PM EDT
134.28
0.00 (0.00%)
After-hours: Jul 27, 2026, 4:10 PM EDT

Apogee Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Cash & Equivalents
451.8131.55141.79118.32
Short-Term Investments
608.09598.64378.86277.14
Cash & Short-Term Investments
1,060730.19520.65395.46
Cash Growth
106.47%40.24%31.66%-
Other Current Assets
13.9111.179.062.95
Total Current Assets
1,074741.36529.71398.41
Net Property, Plant & Equipment
12.9914.3813.322.59
Long-Term Investments
198.35172.73210.42-
Other Long-Term Assets
8.528.670.50.4
Total Assets
1,294937.13753.95401.4

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Accounts Payable
1.241.221.072.14
Accrued Expenses
28.5823.1824.2617.31
Current Portion of Leases
3.143.53.231.1
Total Current Liabilities
32.9527.9128.5620.56
Long-Term Leases
4.915.358.60.93
Total Long-Term Liabilities
4.915.358.60.93
Total Liabilities
37.8633.2537.1621.49

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Common Stock
000-
Additional Paid-in Capital
1,8921,4651,022503.35
Accumulated Other Comprehensive Income
-0.751.080.920.33
Retained Earnings
-635.87-561.76-305.92-123.77
Shareholders' Equity
1,256903.88716.79379.91
Total Liabilities & Equity
1,294937.13753.95401.4

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Total Debt
8.058.8511.832.03
Net Cash (Debt)
1,052721.34508.82393.43
Net Cash Growth
109.73%41.77%29.33%-
Net Cash Per Share
16.5511.899.2215.73
Book Value
1,256903.88716.79379.91
Book Value Per Share
19.7614.8912.9915.19
Tangible Book Value
1,256903.88716.79379.91
Tangible Book Value Per Share
19.7614.8912.9915.19
SEC Filings: 10-K · 10-Q